Literature DB >> 16320274

A Bayesian approach to jointly estimate centre and treatment by centre heterogeneity in a proportional hazards model.

Catherine Legrand1, Vincent Ducrocq, Paul Janssen, Richard Sylvester, Luc Duchateau.   

Abstract

When multicentre clinical trial data are analysed, it has become more and more popular to look for possible heterogeneity in outcome between centres. However, beyond the investigation of such heterogeneity, it is also interesting to consider heterogeneity in treatment effect over centres. For time-to-event outcomes, this may be investigated by including a random centre effect and a random treatment by centre interaction in a Cox proportional hazards model. Assuming independence between the random effects, we propose a Bayesian approach to fit our proposed model. The parameters of interest are the variance components sigma(0) (2) and sigma(1) (2) of these random effects, which can be interpreted as a measure of centre and treatment effect over centres heterogeneity of the hazard. These variance components are estimated from their marginal posterior density after integrating out the fixed treatment effect and the random effects. As this integration cannot be performed analytically, the marginal posterior density is approximated using the Laplace integration technique. Statistical inference is then based on the characteristics of the posterior marginal density, such as the mode and the standard deviation. We demonstrate the proposed technique using data from a pooled database of seven EORTC bladder cancer clinical trials. Substantial centre and treatment effect over centres heterogeneity in disease-free interval was found. Copyright 2005 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2005        PMID: 16320274     DOI: 10.1002/sim.2475

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  8 in total

1.  Validation of prognostic indices using the frailty model.

Authors:  C Legrand; L Duchateau; P Janssen; V Ducrocq; R Sylvester
Journal:  Lifetime Data Anal       Date:  2008-07-11       Impact factor: 1.588

2.  Frailty modelling for survival data from multi-centre clinical trials.

Authors:  Il Do Ha; Richard Sylvester; Catherine Legrand; Gilbert Mackenzie
Journal:  Stat Med       Date:  2011-05-12       Impact factor: 2.373

3.  Interval estimation of random effects in proportional hazards models with frailties.

Authors:  Il Do Ha; Florin Vaida; Youngjo Lee
Journal:  Stat Methods Med Res       Date:  2013-01-29       Impact factor: 3.021

4.  Comparing methods to estimate treatment effects on a continuous outcome in multicentre randomized controlled trials: a simulation study.

Authors:  Rong Chu; Lehana Thabane; Jinhui Ma; Anne Holbrook; Eleanor Pullenayegum; Philip James Devereaux
Journal:  BMC Med Res Methodol       Date:  2011-02-21       Impact factor: 4.615

5.  Individual patient data meta-analysis of survival data using Poisson regression models.

Authors:  Michael J Crowther; Richard D Riley; Jan A Staessen; Jiguang Wang; Francois Gueyffier; Paul C Lambert
Journal:  BMC Med Res Methodol       Date:  2012-03-23       Impact factor: 4.615

6.  The Survival Kit: software to analyze survival data including possibly correlated random effects.

Authors:  G Mészáros; J Sölkner; V Ducrocq
Journal:  Comput Methods Programs Biomed       Date:  2013-02-08       Impact factor: 5.428

7.  Bias and precision of methods for estimating the difference in restricted mean survival time from an individual patient data meta-analysis.

Authors:  Béranger Lueza; Federico Rotolo; Julia Bonastre; Jean-Pierre Pignon; Stefan Michiels
Journal:  BMC Med Res Methodol       Date:  2016-03-29       Impact factor: 4.615

Review 8.  Individual participant data meta-analysis of intervention studies with time-to-event outcomes: A review of the methodology and an applied example.

Authors:  Valentijn M T de Jong; Karel G M Moons; Richard D Riley; Catrin Tudur Smith; Anthony G Marson; Marinus J C Eijkemans; Thomas P A Debray
Journal:  Res Synth Methods       Date:  2020-02-06       Impact factor: 5.273

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.